Outside in: Unraveling the Role of Neuroinflammation in the Progression of Parkinson's Disease
Open Access
- 15 October 2018
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 9, 860
Abstract
Neuroinflammation is one of the most important processes involved in the pathogenesis of Parkinson's disease (PD). The current concept of neuroinflammation comprises an inflammation process, which occurs in the central nervous system due to molecules released from brain-resident and/or blood-derived immune cells. Furthermore, the evidence of the contribution of systemic delivered molecules to the disease pathogenesis, such as the gut microbiota composition, has been increasing during the last years. Under physiological conditions, microglia and astrocytes support the well-being and well-function of the brain through diverse functions, including neurotrophic factor secretion in both intact and injured brain. On the other hand, genes that cause PD are expressed in astrocytes and microglia, shifting their neuroprotective role to a pathogenic one, contributing to disease onset and progression. In addition, growth factors are a subset of molecules that promote cellular survival, differentiation and maturation, which are critical signaling factors promoting the communication between cells, including neurons and blood-derived immune cells. We summarize the potential targeting of astrocytes and microglia and the systemic contribution of the gut microbiota in neuroinflammation process archived in PD.Keywords
Funding Information
- Fondo Nacional de Desarrollo Científico y Tecnológico (1150608, 11160288)
- Comisión Nacional de Investigación Científica y Tecnológica (21160843, 21181114)
This publication has 192 references indexed in Scilit:
- Toll‐like receptor 4 is required for α‐synuclein dependent activation of microglia and astrogliaGlia, 2012
- Meta‐analysis of early nonmotor features and risk factors for Parkinson diseaseAnnals of Neurology, 2012
- The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementiaActa Neuropathologica, 2010
- Clinical progression in Parkinson disease and the neurobiology of axonsAnnals of Neurology, 2010
- The immunoregulatory role of dopamine: An updateBrain, Behavior, and Immunity, 2010
- Astrocytes: biology and pathologyActa Neuropathologica, 2009
- Gabapentin Receptor α2δ-1 Is a Neuronal Thrombospondin Receptor Responsible for Excitatory CNS SynaptogenesisCell, 2009
- A Nurr1/CoREST Pathway in Microglia and Astrocytes Protects Dopaminergic Neurons from Inflammation-Induced DeathCell, 2009
- Olfactory bulb α-synucleinopathy has high specificity and sensitivity for Lewy body disordersActa Neuropathologica, 2008
- Systemic LPS causes chronic neuroinflammation and progressive neurodegenerationGlia, 2007